-
3 weeks ago | 
healio.com | Alan Dow |John Schoen |Andrew Rhoades
NEW ORLEANS — Dementia is a heterogeneous set of diseases that overlap, and it is important to understand specific disease types “so we can think about treatment,” according to Alan Dow, MD, MSHA, FACP. Dow,a Ruth and Seymour Perlin Professor of Medicine and Health Administration at Virginia Commonwealth University and a Healio Primary Care Peer Perspective Board member, highlighted several takeaways from a presentation on the pathophysiology of dementia at the ACP Internal Medicine Meeting.
-
1 month ago | 
healio.com | Deepti Pandita |John Schoen |Andrew Rhoades |Mindy Valcarcel
NEW ORLEANS — AI can be used in multiple ways to help reduce clinician burden, but human oversight is still needed, according to a speaker at the ACP Internal Medicine Meeting. “There is a lot of help coming,”Deepti Pandita, MD, FACP, FAMIA, an associate professor of medicine, vice president of clinical informatics and chief medical information officer at the University of California, Irvine, told Healio.
-
1 month ago | 
healio.com | Alan Dow |John Schoen |Andrew Rhoades |Mindy Valcarcel
NEW ORLEANS — In this video, Alan Dow, MD, MSHA, FACP, discusses evolving cancer screening guidelines and the controversies surrounding some of them. The first screening update involved pancreatic cancer.
-
1 month ago | 
healio.com | Shari M. Erickson |John Schoen |Andrew Rhoades |Mindy Valcarcel
NEW ORLEANS — In this video, Shari M.
-
Oct 29, 2024 | 
healio.com | John Schoen |Carol L. DiBerardino
Read more You've successfully added Vaccine-Preventable Diseases to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Key takeaways:Among those who received two doses of mpox vaccine but never received a smallpox vaccine in childhood, the immune response lasted less than a year.
-
Oct 21, 2024 | 
healio.com | John Schoen |Carol L. DiBerardino
You've successfully added Nosocomial Infections to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected].
-
Oct 21, 2024 | 
healio.com | John Schoen |Carol L. DiBerardino
October 21, 2024 3 min watch VIDEO: Perspective on SHEA featured abstract Add topic to email alerts Please provide your email address to receive an email when new articles are posted on Antimicrobials. Subscribe We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio LOS ANGELES — David J.
-
Oct 19, 2024 | 
healio.com | John Schoen |Carol L. DiBerardino
You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Key takeaways:The 90-day mortality rate was 14.5% in the 7-day arm vs. 16.1% in the 14-day arm. Secondary outcomes were also comparable between the two groups.
-
Aug 20, 2024 | 
healio.com | Cassandra Jenkins |John Schoen
You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected].
-
Aug 2, 2024 | 
healio.com | Lucas Laboy |John Schoen
You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Researchers traced childhood illnesses like asthma, frequent head colds and tonsilitis to the development of chronic rhinosinusitis in middle age in a population-based study.
